Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-alpha response in interferon-beta neutralizing antibody-positive multiple sclerosis
2009-016824-29Phase 2Completed
- Sponsor
- Danish Multiple Sclerosis Center
- Start
- Feb 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon alfa in multiple sclerosis (MS), sponsored by Danish Multiple Sclerosis Center. Started Feb 2010; status: completed.
02
Drugs
interferon alfa
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-016824-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016824-29.